Rare Neurology News

Advertisement

Spotlight On

Achondroplasia

Achondroplasia is a disorder of bone growth that prevents the changing of cartilage - particularly in the long bones of the arms and legs - to bone

Prevalence

3,310-29,790

US Estimated

5,135-46,215

Europe Estimated

Age of Onset

ICD-10

Q77.4

Inheritance

Autosomal dominant

Autosomal recessive

Mitochondrial/Multigenic

X-linked dominant

X-linked recessive

5 Facts you should know

FACT

1

Achondroplasia is the most common form of short stature

 

FACT

2

In those with the condition, the arms and legs are short, while the torso is typically of normal length

 

FACT

3

Those affected have an average adult height of 4 ft 4 in for males and 4 ft for females

 

FACT

4

Other features can include an enlarged head and prominent forehead

 

FACT

5

Achondroplasia is caused by a mutation in the FGFR3 gene that results in overactive signaling

 

Achondroplasia is also known as...

Achondroplasia is also known as:

  • ACH
  • Achondroplastic dwarfism
     

What’s your Rare IQ?

What percentage of cases of disproportionate short stature are caused by achondroplasia?

Common signs & symptoms

Bowing of the legs

Thoracolumbar kyphosis

Abnormality of the shape of the midface

Hearing impairment

Infantile muscular hypotonia

Lumbar hyperlordosis

Macrocephaly

Hypoxemia

Current treatments

Recommendations for management of children with achondroplasia were outlined by the American Academy of Pediatrics Committee on Genetics in the article, Health Supervision for Children with Achondroplasia. We recommend that you review this article with your child’s health care provider(s). These recommendations include:

Monitoring of height, weight, and head circumference using growth curves standardized for achondroplasia

Careful neurologic examinations, with referral to a pediatric neurologist as necessary

MRI or CT of the foramen magnum region for evaluation of severe hypotonia or signs of spinal cord compression

Referral to a pediatric orthopedist if bowing of the legs interferes with walking

Management of frequent middle-ear infections

Speech evaluation by age two years

Careful monitoring of social adjustment

(Brand name: Voxzogo) Manufactured by BioMarin, Inc.

Vosoritide is a C-type natriuretic peptide (CNP) analog that is given by subcutaneous injection and may be used to increase linear bone growth in children with achondroplasia with open bone growth plates (epiphyses).

Top Clinical Trials

Top Treatments in Research